Balchem Corporation (BCPC) Earnings Call Analysis

NASDAQ · Basic Materials · Specialty Chemicals

22/25

Growth 5 Margin 5 Expansion 5 Platform 2 Financial 5

latest quarter score

Earnings Reports

22
Balchem (BCPC) Q2 2026: Animal Nutrition Surges 15% on Europe Price Recovery
July 31, 2026
24
Balchem (BCPC) Q1 2026: Gross Margin Expands 210bps as Branded Nutrients Fuel 27th Growth Quarter
April 30, 2026
22
Balchem (BCPC) Q4 2025: International Sales Fuel 9.8% Revenue Surge as Segment Growth Diversifies
February 23, 2026
24
Balchem (BCPC) Q3 2025: Human Nutrition Sales Jump 14% as “Better-For-You” Trends Accelerate
October 21, 2025
24
Balchem (BCPC) Q2 2025: Microencapsulation Capacity to Double as Nutrient Portfolio Delivers 9% Growth
July 31, 2025
20
Balchem (BCPC) Q1 2025: EBITDA Margin Expands 106bps as Supply Chain Flex Shields Against Tariff Risk
July 06, 2025
Balchem (BCPC) Q3 2024: Human Nutrition and Health Drives 5.4% Segment Growth, Margin Expansion Signals Mix Shift
October 25, 2024
Balchem (BCPC) Q2 2024: Human Nutrition & Health Up 9%, Margin Mix Drives 210bps Expansion
July 26, 2024
Balchem (BCPC) Q1 2024: Human Nutrition and Health Surges 15% as Animal Segment Faces Import Pressure
May 03, 2024
Balchem (BCPC) Q4 2023: Human Nutrition & Health Rises 5.8%, Offsetting Animal Segment Drag
February 16, 2024
Balchem (BCPC) Q3 2023: Gross Margin Expands 530bps as Human Nutrition Drives Profitability
October 27, 2023
Balchem (BCPC) Q1 2023: Gross Margin Rebounds to 31.5% as Pricing Powers Sequential Recovery
April 28, 2023

Browse all companies